Yan-Ping Mao, Wen-Fei Li, Lei Chen, Ying Sun, Li-Zhi Liu, Ling-Long Tang, Su-Mei Cao, Ai-Hua Lin, Ming-Huang Hong, Tai-Xiang Lu, Meng-Zhong Liu, Li Li, Jun Ma
{"title":"[A clinical verification of the Chinese 2008 staging system for nasopharyngeal carcinoma].","authors":"Yan-Ping Mao, Wen-Fei Li, Lei Chen, Ying Sun, Li-Zhi Liu, Ling-Long Tang, Su-Mei Cao, Ai-Hua Lin, Ming-Huang Hong, Tai-Xiang Lu, Meng-Zhong Liu, Li Li, Jun Ma","doi":"10.5732/cjc.009.10425","DOIUrl":null,"url":null,"abstract":"<p><strong>Background and objective: </strong>The Chinese 2008 staging system for nasopharyngeal carcinoma (NPC) was a common set of recommendations by initial revision of the previous'92 staging system. This study was to verify the Chinese 2008 staging system and to provide evidence for its further revision.</p><p><strong>Methods: </strong>Between January 2003 and December 2004, 924 consecutive patients with newly diagnosed, nondisseminated biopsy-proven NPC, presented at the Department of Radiation Oncology, Cancer Center, Sun Yat-sen University, were entered into our study. All patients received magnetic resonance imaging examination of the neck and nasopharynx before treatment. According to the principle of the staging system, the indices of hazard consistency, hazard discrimination, prognostic value, and distribution were used to evaluate the Chinese 2008 staging system.</p><p><strong>Results: </strong>According to the Chinese 2008 staging system, the distribution of stage group for the whole series was 4.9% for the stage I, 22.6% stage II, 38.0% stage III, and 34.5% stage IVA. As for hazard discrimination, the 4-year local relapse-free survival (LRFS) rates for T1-T4 patients were 95.4%, 93.7%, 90.5% and 79.1%, respectively. Although the separation of LRFS for all subclassifications of T-stage showed reasonable, the differences among the subgroups T1, T2, and T3 were still lack of significant statistically. The 4-year distant metastasis failure-free survival (DMFS) rates for N0-N3 patients were 89.4%, 84.3%, 73.6, and 59.2%, respectively. The 4-year overall survival (OS) rates for stage I-IV patients were 96.7%, 94.1%, 82.6% and 67.1%, respectively. As for hazard consistency, the distinctions between T3 with skull base involvement and T3 with medial pterygoid muscle in the hazard ratios of local failure (1.628 vs. 3.905) and disease failure (1.630 vs. 3.288) were large. Multivariate analyses showed that cervical nodal level, extranodal neoplastic spread, and laterality were independent prognostic factors for OS and DMFS, but maximal axial diameter was not.</p><p><strong>Conclusion: </strong>Using the Chinese 2008 staging system for NPC produces an acceptable distribution of patient numbers. Stage group, T classification, and N classification represent independent prognosis factors for major endpoints. However, our study reveals several deficiencies in the current system yet.</p>","PeriodicalId":7559,"journal":{"name":"Ai zheng = Aizheng = Chinese journal of cancer","volume":"28 10","pages":"1022-8"},"PeriodicalIF":0.0000,"publicationDate":"2009-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"27","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Ai zheng = Aizheng = Chinese journal of cancer","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5732/cjc.009.10425","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 27
Abstract
Background and objective: The Chinese 2008 staging system for nasopharyngeal carcinoma (NPC) was a common set of recommendations by initial revision of the previous'92 staging system. This study was to verify the Chinese 2008 staging system and to provide evidence for its further revision.
Methods: Between January 2003 and December 2004, 924 consecutive patients with newly diagnosed, nondisseminated biopsy-proven NPC, presented at the Department of Radiation Oncology, Cancer Center, Sun Yat-sen University, were entered into our study. All patients received magnetic resonance imaging examination of the neck and nasopharynx before treatment. According to the principle of the staging system, the indices of hazard consistency, hazard discrimination, prognostic value, and distribution were used to evaluate the Chinese 2008 staging system.
Results: According to the Chinese 2008 staging system, the distribution of stage group for the whole series was 4.9% for the stage I, 22.6% stage II, 38.0% stage III, and 34.5% stage IVA. As for hazard discrimination, the 4-year local relapse-free survival (LRFS) rates for T1-T4 patients were 95.4%, 93.7%, 90.5% and 79.1%, respectively. Although the separation of LRFS for all subclassifications of T-stage showed reasonable, the differences among the subgroups T1, T2, and T3 were still lack of significant statistically. The 4-year distant metastasis failure-free survival (DMFS) rates for N0-N3 patients were 89.4%, 84.3%, 73.6, and 59.2%, respectively. The 4-year overall survival (OS) rates for stage I-IV patients were 96.7%, 94.1%, 82.6% and 67.1%, respectively. As for hazard consistency, the distinctions between T3 with skull base involvement and T3 with medial pterygoid muscle in the hazard ratios of local failure (1.628 vs. 3.905) and disease failure (1.630 vs. 3.288) were large. Multivariate analyses showed that cervical nodal level, extranodal neoplastic spread, and laterality were independent prognostic factors for OS and DMFS, but maximal axial diameter was not.
Conclusion: Using the Chinese 2008 staging system for NPC produces an acceptable distribution of patient numbers. Stage group, T classification, and N classification represent independent prognosis factors for major endpoints. However, our study reveals several deficiencies in the current system yet.
背景与目的:中国2008年鼻咽癌分期系统是对1992年鼻咽癌分期系统进行初步修订后的一套通用推荐标准。本研究旨在验证中国2008分级体系,并为其进一步修订提供依据。方法:2003年1月至2004年12月,中山大学肿瘤中心放射肿瘤科连续924例新诊断、非播散性活检证实的鼻咽癌患者纳入我们的研究。所有患者治疗前均行颈部及鼻咽部磁共振成像检查。根据分期系统原理,采用风险一致性、风险鉴别、预后价值和分布等指标对中国2008年分期系统进行评价。结果:按照中国2008年分期体系,全系列分期组分布为:ⅰ期4.9%,ⅱ期22.6%,ⅲ期38.0%,IVA期34.5%。在危险区分方面,T1-T4患者4年局部无复发生存率(LRFS)分别为95.4%、93.7%、90.5%和79.1%。虽然各t期亚分类LRFS分离合理,但T1、T2、T3亚组间差异仍无统计学意义。N0-N3患者的4年远处转移无失败生存率(DMFS)分别为89.4%、84.3%、73.6%和59.2%。I-IV期患者的4年总生存率(OS)分别为96.7%、94.1%、82.6%和67.1%。在风险一致性方面,累及颅底的T3与翼状内侧肌的T3在局部失败(1.628 vs. 3.905)和疾病失败(1.630 vs. 3.288)的风险比上差异较大。多因素分析显示,宫颈淋巴结水平、结外肿瘤扩散和侧位是OS和DMFS的独立预后因素,但最大轴径不是。结论:采用中国2008年鼻咽癌分期系统,患者数量分布可接受。分期组、T分型和N分型是主要终点独立的预后因素。然而,我们的研究也揭示了现行制度的一些不足之处。